Opaleye Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,222
| Closed | -$8.04M | – | 51 |
|
|
2019
Q3 | $8.04M | Buy |
+12,222
| New | +$8.04M | 2.91% | 12 |
|
|
2019
Q2 | – | Sell |
-5,556
| Closed | -$3.92M | – | 53 |
|
|
2019
Q1 | $3.92M | Buy |
+5,556
| New | +$3.92M | 1.09% | 35 |
|
|
2018
Q4 | – | Sell |
-3,611
| Closed | -$3.11M | – | 55 |
|
|
2018
Q3 | $3.11M | Buy |
+3,611
| New | +$3.11M | 0.79% | 33 |
|
|
2017
Q2 | – | Sell |
-10,694
| Closed | -$7.08M | – | 50 |
|
|
2017
Q1 | $7.08M | Sell |
10,694
-2,500
| -19% | -$1.66M | 3.52% | 7 |
|
|
2016
Q4 | $4.41M | Sell |
13,194
-5,556
| -30% | -$1.86M | 2.6% | 14 |
|
|
2016
Q3 | $5.64M | Sell |
18,750
-4,444
| -19% | -$1.34M | 2.95% | 8 |
|
|
2016
Q2 | $4.02M | Sell |
23,194
-556
| -2% | -$96.3K | 2.68% | 12 |
|
|
2016
Q1 | $5.32M | Buy |
23,750
+11,889
| +100% | +$2.66M | 3.32% | 8 |
|
|
2015
Q4 | $7.2M | Buy |
11,861
+333
| +3% | +$202K | 3.01% | 13 |
|
|
2015
Q3 | $5.93M | Buy |
11,528
+2,084
| +22% | +$1.07M | 2.92% | 14 |
|
|
2015
Q2 | $4.13M | Buy |
9,444
+694
| +8% | +$304K | 1.64% | 24 |
|
|
2015
Q1 | $3.17M | Buy |
8,750
+6,528
| +294% | +$2.36M | 1.47% | 26 |
|
|
2014
Q4 | $798K | Buy |
+2,222
| New | +$798K | 0.4% | 35 |
|